- Home
- HCWB vs AWX Comparison
HCWB vs AWX Comparison
Compare HCWB & AWX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HCWB
- AWX
- Stock Information
- Founded
- HCWB 2018
- AWX 1998
- Country
- HCWB United States
- AWX United States
- Employees
- HCWB N/A
- AWX N/A
- Industry
- HCWB Biotechnology: Pharmaceutical Preparations
- AWX Environmental Services
- Sector
- HCWB Health Care
- AWX Utilities
- Exchange
- HCWB Nasdaq
- AWX Nasdaq
- Market Cap
- HCWB 8.7M
- AWX 10.1M
- IPO Year
- HCWB 2021
- AWX 1998
- Fundamental
- Price
- HCWB $4.00
- AWX $2.56
- Analyst Decision
- HCWB Strong Buy
- AWX
- Analyst Count
- HCWB 1
- AWX 0
- Target Price
- HCWB $35.00
- AWX N/A
- AVG Volume (30 Days)
- HCWB 1.3M
- AWX 3.5K
- Earning Date
- HCWB 11-13-2025
- AWX 11-07-2025
- Dividend Yield
- HCWB N/A
- AWX N/A
- EPS Growth
- HCWB N/A
- AWX 306.94
- EPS
- HCWB N/A
- AWX 0.03
- Revenue
- HCWB $832,841.00
- AWX $78,200,000.00
- Revenue This Year
- HCWB $178.64
- AWX N/A
- Revenue Next Year
- HCWB N/A
- AWX N/A
- P/E Ratio
- HCWB N/A
- AWX $84.89
- Revenue Growth
- HCWB N/A
- AWX N/A
- 52 Week Low
- HCWB $2.77
- AWX $2.10
- 52 Week High
- HCWB $100.80
- AWX $3.99
- Technical
- Relative Strength Index (RSI)
- HCWB 47.15
- AWX 51.11
- Support Level
- HCWB $3.66
- AWX $2.50
- Resistance Level
- HCWB $4.13
- AWX $2.63
- Average True Range (ATR)
- HCWB 0.21
- AWX 0.05
- MACD
- HCWB 0.00
- AWX 0.00
- Stochastic Oscillator
- HCWB 34.60
- AWX 54.05
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.
About AWX Avalon Holdings Corporation
Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.